What Is Retatrutide? — Mechanism, Research & Safety

Overview

Retatrutide is classified as a triple agonist (glp-1/gip/glucagon) peptide. Superior body recomposition, massive fat loss, metabolic health.

Multi-receptor activation for appetite suppression, fat oxidation, energy expenditure. Unique triple agonism at GLP-1, GIP, and glucagon receptors delivers synergistic metabolic effects unmatched by single or dual agonists.

Also known as: LY3437943

How Does Retatrutide Work?

At the molecular level, Retatrutide operates through pathways characteristic of the Triple Agonist (GLP-1/GIP/Glucagon) class, interacting with target receptors and downstream signaling cascades to produce its observed effects.

Published Research

The following studies are indexed from PubMed and peer-reviewed journals:

[1]Retatrutide Phase 2 trial: ~24% weight loss at 48 weeks

Jastreboff et al. (NEJM): Phase 2 RCT showing 24.2% body weight reduction at 12mg dose over 48 weeks the highest reported weight loss in any obesity drug trial to date.

Evidence: strong

[2]Retatrutide Phase 1 safety and dose-dependent weight loss

First-in-human Phase 1 trial demonstrating dose-dependent weight loss, favorable safety profile, and significant HbA1c reductions across multiple dose levels.

Evidence: moderate

[3]Retatrutide reduces liver fat (NAFLD sub-study)

Phase 2 sub-study showing retatrutide significantly reduces liver fat content, with ~90% of participants with baseline steatosis achieving resolution at 48 weeks.

Evidence: strong

[4]Triple GLP-1/GIP/glucagon agonism pharmacological rationale

Review of the triple agonism mechanism: GLP-1 provides appetite suppression, GIP enhances GH-like metabolic effects, and glucagon drives energy expenditure and hepatic lipid oxidation.

Evidence: moderate

Safety Profile

GI side effects (nausea, diarrhea) common; investigational not FDA-approved as of 2026. Phase 3 TRIUMPH trials ongoing.

Side Effect	Incidence	Severity
Nausea	~45% of users	moderate
Diarrhea	~25% of users	mild
Vomiting	~20% of users	moderate
Constipation	~20% of users	mild

Sourcing Retatrutide for Research

If you're looking to source Retatrutide for laboratory research, our vendor directory compares pricing, purity testing, and COA verification from independently vetted suppliers.

Check Current Market Pricing Compare Vendors Side by Side

Disclosure: PeptiDex may earn a commission from affiliate links. This does not affect our recommendations.

Full Research Profile

Retatrutide — dosing, interactions, timelines & more

Comprehensive compound profile with sourcing information, stacking synergies, and outcome timelines.